Anika Therapeutics ANIK

$ 16.51 1.1%

Quarterly report 2024-Q3
added 11-04-2024

Anika Therapeutics EV/EBITDA Ratio 2011-2024 | ANIK

Annual EV/EBITDA Ratio Anika Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
38.7	-430	11.2	16.6	17.2	11.5	8.69	7.18	11	3.99	5.25

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
38.7	-430	-27.1